Delta-Fly Pharma,Inc. [4598.T]

TOKYO, Apr 17 (Pulse News Wire) – Delta-fly Pharma,inc. (4598.T) reported the massive exercise of warrant shares during the period from April 1 to April 17, 2026.

According to the disclosure, Macquarie Bank Limited exercised warrants totaling 8,200 units out of the total issuance of 27.33% units, representing 19,849% of the total issuance. As of March 31, there were __NUM_4__ unexercised warrants outstanding, which decreased to 11,649 unexercised warrants as of the latest report.

The detailed exercise status from April 1, 2026, showed the following: | Exercise Date | Number of New Shares Issued | Transfer of Treasury Shares | Exercised Warrants | |--------------|---------------------------|----------------------------|--------------------| | April 1, 2026 | - | - | 186 | | April 3, 2026 | 30,000 | - | 174 | | April 6, 2026 | 50,000 | - | 170 | | April 8, 2026 | 50,000 | - | 176 | | April 14, 2026 | 30,000 | - | 175 | | April 15, 2026 | 30,000 | - | 177 | | April 16, 2026 | 30,000 | - | 180 | | April 17, 2026 | 600,000 | - | 181 | As of the end of March 2026, the total number of issued shares was 13,175,000, including 198 treasury shares.

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.